{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T12:11:51Z","timestamp":1771675911147,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T00:00:00Z","timestamp":1736985600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T00:00:00Z","timestamp":1736985600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Beijing Research Center for Respiratory Infectious Diseases Project","award":["BJRID2024-001"],"award-info":[{"award-number":["BJRID2024-001"]}]},{"name":"Beijing Research Ward Excellence Program","award":["BRWEP2024W042180101"],"award-info":[{"award-number":["BRWEP2024W042180101"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-10459-8","type":"journal-article","created":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T12:18:03Z","timestamp":1737029883000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Safety and recommendation of voriconazole for invasive pulmonary aspergillosis in severe liver disease patients: a retrospective cohort study"],"prefix":"10.1186","volume":"25","author":[{"given":"Xin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caopei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuqing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijun","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yulin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,16]]},"reference":[{"key":"10459_CR1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac927","author":"DZP Friedman","year":"2023","unstructured":"Friedman DZP, Johnson BK, Beam E, Kremers WK, Vergidis P. Risk factors and outcomes of invasive aspergillosis in kidney transplant recipients: a case-control study of United States Renal Data System Data. Clin Infect diseases: official publication Infect Dis Soc Am. 2023;76(8):1431\u20139. https:\/\/doi.org\/10.1093\/cid\/ciac927"},{"issue":"Suppl 7","key":"10459_CR2","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/imj.15591","volume":"51","author":"AP Douglas","year":"2021","unstructured":"Douglas AP, Smibert OC, Bajel A, Halliday CL, Lavee O, McMullan B, Yong MK, van Hal SJ, Chen SC. Consensus guidelines for the diagnosis and management of invasive aspergillosis, 2021. Intern Med J. 2021;51(Suppl 7):143\u201376. https:\/\/doi.org\/10.1111\/imj.15591","journal-title":"Intern Med J"},{"issue":"3","key":"10459_CR3","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/liv.13981","volume":"39","author":"N Verma","year":"2019","unstructured":"Verma N, Singh S, Taneja S, Duseja A, Singh V, Dhiman RK, Chakrabarti A, Chawla YK. Invasive fungal infections amongst patients with acute-on-chronic liver failure at high risk for fungal infections. Liver Int. 2019;39(3):503\u201313. https:\/\/doi.org\/10.1111\/liv.13981","journal-title":"Liver Int"},{"issue":"2","key":"10459_CR4","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/myc.13403","volume":"65","author":"T Lahmer","year":"2022","unstructured":"Lahmer T, Pe\u00e7anha-Pietrobom PM, Schmid RM, Colombo AL. Invasive fungal infections in acute and chronic liver impairment: a systematic review. Mycoses. 2022;65(2):140\u201351. https:\/\/doi.org\/10.1111\/myc.13403","journal-title":"Mycoses"},{"issue":"12","key":"10459_CR5","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.7150\/ijms.6824","volume":"10","author":"J Chen","year":"2013","unstructured":"Chen J, Yang Q, Huang J, Li L. Risk factors for invasive pulmonary aspergillosis and hospital mortality in acute-on-chronic liver failure patients: a retrospective-cohort study. Int J Med Sci. 2013;10(12):1625\u201331. https:\/\/doi.org\/10.7150\/ijms.6824","journal-title":"Int J Med Sci"},{"issue":"1","key":"10459_CR6","doi-asserted-by":"publisher","first-page":"11919","DOI":"10.1038\/s41598-019-48183-4","volume":"9","author":"T Lahmer","year":"2019","unstructured":"Lahmer T, Brandl A, Rasch S, Baires GB, Schmid RM, Huber W, Mayr U. Prevalence and outcome of invasive pulmonary aspergillosis in critically ill patients with liver cirrhosis: an observational study. Sci Rep. 2019;9(1):11919. https:\/\/doi.org\/10.1038\/s41598-019-48183-4","journal-title":"Sci Rep"},{"issue":"1","key":"10459_CR7","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13613-019-0502-2","volume":"9","author":"E Levesque","year":"2019","unstructured":"Levesque E, Ait-Ammar N, Dudau D, Clavieras N, Feray C, Foulet F, Botterel F. Invasive pulmonary aspergillosis in cirrhotic patients: analysis of a 10-year clinical experience. Ann Intensive Care. 2019;9(1):31. https:\/\/doi.org\/10.1186\/s13613-019-0502-2","journal-title":"Ann Intensive Care"},{"issue":"11","key":"10459_CR8","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1093\/mmy\/myab044","volume":"59","author":"N Verma","year":"2021","unstructured":"Verma N, Singh S, Syal A, Pradhan P, Singh M, Singh M. Invasive aspergillosis is a critical determinant of mortality in cirrhosis: a systematic review with meta-analysis. Med Mycol. 2021;59(11):1092\u2013100. https:\/\/doi.org\/10.1093\/mmy\/myab044","journal-title":"Med Mycol"},{"key":"10459_CR9","doi-asserted-by":"publisher","unstructured":"Jenks JD, Hoenigl M. Treatment of aspergillosis. Journal of fungi (Basel, Switzerland). 2018;4(3). https:\/\/doi.org\/10.3390\/jof4030098","DOI":"10.3390\/jof4030098"},{"issue":"7","key":"10459_CR10","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1248\/bpb.b18-00164","volume":"41","author":"T Yamada","year":"2018","unstructured":"Yamada T, Imai S, Koshizuka Y, Tazawa Y, Kagami K, Tomiyama N, Sugawara R, Yamagami A, Shimamura T, Iseki K. Necessity for a significant maintenance dosage reduction of voriconazole in patients with severe liver cirrhosis (child-Pugh class C). Biol Pharm Bull. 2018;41(7):1112\u20138. https:\/\/doi.org\/10.1248\/bpb.b18-00164","journal-title":"Biol Pharm Bull"},{"issue":"2","key":"10459_CR11","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1002\/hep.31884","volume":"74","author":"SW Biggins","year":"2021","unstructured":"Biggins SW, Angeli P, Garcia-Tsao G, Gin\u00e8s P, Ling SC, Nadim MK, Wong F, Kim WR. Diagnosis, evaluation, and management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: 2021 practice guidance by the American Association for the study of liver diseases. Hepatology. 2021;74(2):1014\u201348. https:\/\/doi.org\/10.1002\/hep.31884","journal-title":"Hepatology"},{"issue":"1","key":"10459_CR12","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3760\/cma.j.issn.1007-3418.2019.01.006","volume":"27","author":"Liver Failure and Artificial Liver Group CSoID, Chinese Medical Association., Severe Liver Disease and Artificial Liver Group CSoH, Chinese Medical Association","year":"2019","unstructured":"Liver Failure and Artificial Liver Group CSoID, Chinese Medical Association., Severe Liver Disease and Artificial Liver Group CSoH, Chinese Medical Association. Guideline for diagnosis and treatment of liver failure. Chin J Hepatol. 2019;27(1):18\u201326. https:\/\/doi.org\/10.3760\/cma.j.issn.1007-3418.2019.01.006","journal-title":"Chin J Hepatol"},{"key":"10459_CR13","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000466","author":"AG Singal","year":"2023","unstructured":"Singal AG, Llovet JM, Yarchoan M, Mehta N, Heimbach JK, Dawson LA, Jou JH, Kulik LM, Agopian VG, Marrero JA, et al. AASLD practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma. Hepatology. 2023. https:\/\/doi.org\/10.1097\/HEP.0000000000000466","journal-title":"Hepatology"},{"issue":"6","key":"10459_CR14","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","volume":"71","author":"JP Donnelly","year":"2020","unstructured":"Donnelly JP, Chen SC, Kauffman CA, Steinbach WJ, Baddley JW, Verweij PE, Clancy CJ, Wingard JR, Lockhart SR, Groll AH. Revision and update of the consensus definitions of invasive fungal disease from the European Organization for research and treatment of cancer and the Mycoses Study Group Education and Research Consortium. Clin Infect Diseases: Official Publication Infect Dis Soc Am. 2020;71(6):1367\u201376. https:\/\/doi.org\/10.1093\/cid\/ciz1008","journal-title":"Clin Infect Diseases: Official Publication Infect Dis Soc Am"},{"key":"10459_CR15","doi-asserted-by":"publisher","unstructured":"Costa-Pinto R, Klink S, Rotherham H, Perera P, Finlay L, Urbancic K, Vaz K, Trubiano J, Bellomo R. Assessing the safety profile of voriconazole use in suspected COVID-19-associated pulmonary aspergillosis-a two-centre observational study. Med Mycol. 2023;61(6). https:\/\/doi.org\/10.1093\/mmy\/myad054","DOI":"10.1093\/mmy\/myad054"},{"issue":"6","key":"10459_CR16","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s15010-017-1042-z","volume":"45","author":"R Bellmann","year":"2017","unstructured":"Bellmann R, Smuszkiewicz P. Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients. Infection. 2017;45(6):737\u201379. https:\/\/doi.org\/10.1007\/s15010-017-1042-z","journal-title":"Infection"},{"issue":"3","key":"10459_CR17","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.ijantimicag.2014.08.012","volume":"45","author":"II Raad","year":"2015","unstructured":"Raad II, Zakhem AE, Helou GE, Jiang Y, Kontoyiannis DP, Hachem R. Clinical experience of the use of voriconazole, caspofungin or the combination in primary and salvage therapy of invasive aspergillosis in haematological malignancies. Int J Antimicrob Agents. 2015;45(3):283\u20138. https:\/\/doi.org\/10.1016\/j.ijantimicag.2014.08.012","journal-title":"Int J Antimicrob Agents"},{"key":"10459_CR18","doi-asserted-by":"publisher","unstructured":"Henao-Mart\u00ednez AF, Corbisiero MF, Salter I, Chastain DB, Thompson GR. Invasive pulmonary aspergillosis real-world outcomes: clinical features and risk factors associated with increased mortality. Med Mycol. 2023;61(8). https:\/\/doi.org\/10.1093\/mmy\/myad074","DOI":"10.1093\/mmy\/myad074"},{"issue":"3","key":"10459_CR19","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.amjmed.2015.10.029","volume":"129","author":"V Lo Re","year":"2016","unstructured":"Lo Re V 3rd, Carbonari DM, Lewis JD, Forde KA, Goldberg DS, Reddy KR, Haynes K, Roy JA, Sha D, Marks AR, et al. Oral azole antifungal medications and risk of acute liver injury, overall and by chronic liver disease status. Am J Med. 2016;129(3):283\u2013e291285. https:\/\/doi.org\/10.1016\/j.amjmed.2015.10.029","journal-title":"Am J Med"},{"issue":"8","key":"10459_CR20","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1111\/myc.13129","volume":"63","author":"Y Hamada","year":"2020","unstructured":"Hamada Y, Ueda T, Miyazaki Y, Nakajima K, Fukunaga K, Miyazaki T, Nakada-Motokawa N, Nagao M, Kawamura H, Shigemi A, et al. Effects of antifungal stewardship using therapeutic drug monitoring in voriconazole therapy on the prevention and control of hepatotoxicity and visual symptoms: a multicentre study conducted in Japan. Mycoses. 2020;63(8):779\u201386. https:\/\/doi.org\/10.1111\/myc.13129","journal-title":"Mycoses"},{"issue":"7","key":"10459_CR21","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1093\/jac\/dkw045","volume":"71","author":"H Jin","year":"2016","unstructured":"Jin H, Wang T, Falcione BA, Olsen KM, Chen K, Tang H, Hui J, Zhai S. Trough concentration of voriconazole and its relationship with efficacy and safety: a systematic review and meta-analysis. J Antimicrob Chemother. 2016;71(7):1772\u201385. https:\/\/doi.org\/10.1093\/jac\/dkw045","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10459_CR22","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, Harrison SA, Brunt EM, Sanyal AJ. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the study of liver diseases. Hepatology. 2018;67(1):328\u201357. https:\/\/doi.org\/10.1002\/hep.29367","journal-title":"Hepatology"},{"issue":"1","key":"10459_CR23","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s13054-022-04163-1","volume":"26","author":"A de Perez Ruiz","year":"2022","unstructured":"de Perez Ruiz A, Kortgen A, Leonhardt J, Zipprich A, Bauer M. Critical care hepatology: definitions, incidence, prognosis and role of liver failure in critically ill patients. Crit Care. 2022;26(1):289. https:\/\/doi.org\/10.1186\/s13054-022-04163-1","journal-title":"Crit Care"},{"issue":"9","key":"10459_CR24","doi-asserted-by":"publisher","first-page":"100239","DOI":"10.1016\/j.modpat.2023.100239","volume":"36","author":"LW Lamps","year":"2023","unstructured":"Lamps LW. A pattern-based approach to hepatic infections. Mod Pathol. 2023;36(9):100239. https:\/\/doi.org\/10.1016\/j.modpat.2023.100239","journal-title":"Mod Pathol"},{"issue":"6","key":"10459_CR25","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1093\/infdis\/jiy261","volume":"218","author":"Y Karimata","year":"2018","unstructured":"Karimata Y, Kinjo T, Parrott G, Uehara A, Nabeya D, Haranaga S, Higa F, Tateyama M, Miyagawa K, Kishaba T, et al. Clinical features of human metapneumovirus pneumonia in non-immunocompromised patients: an investigation of three long-term care facility outbreaks. J Infect Dis. 2018;218(6):868\u201375. https:\/\/doi.org\/10.1093\/infdis\/jiy261","journal-title":"J Infect Dis"},{"issue":"1","key":"10459_CR26","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1038\/s41598-018-19320-2","volume":"8","author":"J Gao","year":"2018","unstructured":"Gao J, Zhang Q, Wu Y, Li Y, Qi T, Zhu C, Liu S, Yu R, He Q, Wen W, et al. Improving survival of acute-on-chronic liver failure patients complicated with invasive pulmonary aspergillosis. Sci Rep. 2018;8(1):876. https:\/\/doi.org\/10.1038\/s41598-018-19320-2","journal-title":"Sci Rep"},{"key":"10459_CR27","doi-asserted-by":"publisher","first-page":"1242711","DOI":"10.3389\/fgene.2023.1242711","volume":"14","author":"G Li","year":"2023","unstructured":"Li G, Li Q, Zhang C, Yu Q, Li Q, Zhou X, Yang R, Yang X, Liu H, Yang Y. The impact of gene polymorphism and hepatic insufficiency on voriconazole dose adjustment in invasive fungal infection individuals. Front Genet. 2023;14:1242711. https:\/\/doi.org\/10.3389\/fgene.2023.1242711","journal-title":"Front Genet"},{"key":"10459_CR28","doi-asserted-by":"publisher","first-page":"5405","DOI":"10.2147\/idr.S419382","volume":"16","author":"L Gu","year":"2023","unstructured":"Gu L, Ai T, Pang L, Xu D, Wang H. Voriconazole-induced hepatotoxicity in a patient with pulmonary aspergillosis: a case report. Infect drug Resist. 2023;16:5405\u201311. https:\/\/doi.org\/10.2147\/idr.S419382","journal-title":"Infect drug Resist"},{"key":"10459_CR29","doi-asserted-by":"publisher","unstructured":"Tang D, Song BL, Yan M, Zou JJ, Zhang M, Zhou HY, Wang F, Xiao YW, Xu P, Zhang BK et al. Identifying factors affecting the pharmacokinetics of voriconazole in patients with liver dysfunction: a population pharmacokinetic approach. Basic & clinical pharmacology & toxicology. 2019;125(1):34\u201343. https:\/\/doi.org\/10.1111\/bcpt.13208","DOI":"10.1111\/bcpt.13208"},{"issue":"6","key":"10459_CR30","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1097\/ftd.0000000000000561","volume":"40","author":"K Chen","year":"2018","unstructured":"Chen K, Zhang X, Ke X, Du G, Yang K, Zhai S. Individualized medication of voriconazole: a practice guideline of the division of therapeutic drug monitoring, Chinese Pharmacological Society. Ther Drug Monit. 2018;40(6):663\u201374. https:\/\/doi.org\/10.1097\/ftd.0000000000000561","journal-title":"Ther Drug Monit"},{"issue":"2","key":"10459_CR31","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1002\/phar.2474","volume":"41","author":"T Wang","year":"2021","unstructured":"Wang T, Yan M, Tang D, Dong Y, Zhu L, Du Q, Sun D, Xing J, Dong Y. Using child-pugh class to optimize voriconazole dosage regimens and improve safety in patients with liver cirrhosis: insights from a population pharmacokinetic model-based analysis. Pharmacotherapy. 2021;41(2):172\u201383. https:\/\/doi.org\/10.1002\/phar.2474","journal-title":"Pharmacotherapy"},{"issue":"9","key":"10459_CR32","doi-asserted-by":"publisher","first-page":"4793","DOI":"10.1128\/aac.00626-12","volume":"56","author":"MJ Dolton","year":"2012","unstructured":"Dolton MJ, Ray JE, Chen SC, Ng K, Pont LG, McLachlan AJ. Multicenter study of voriconazole pharmacokinetics and therapeutic drug monitoring. Antimicrob Agents Chemother. 2012;56(9):4793\u20139. https:\/\/doi.org\/10.1128\/aac.00626-12","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10459_CR33","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1007\/s40121-021-00524-5","volume":"10","author":"D Chen","year":"2021","unstructured":"Chen D, Qian Z, Su H, Meng Z, Lv J, Huang Y, Gao Y, Liu J, Zhao C, Gao H, et al. Invasive pulmonary aspergillosis in acute-on-chronic liver failure patients: short-term outcomes and antifungal options. Infect Dis Therapy. 2021;10(4):2525\u201338. https:\/\/doi.org\/10.1007\/s40121-021-00524-5","journal-title":"Infect Dis Therapy"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-10459-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-10459-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-10459-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T12:18:09Z","timestamp":1737029889000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-10459-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,16]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10459"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-10459-8","relation":{"references":[{"id-type":"uri","id":"","asserted-by":"subject"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,16]]},"assertion":[{"value":"13 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki, and received approval from the ethics committee of Beijing Youan Hospital, Capital Medical University (no. LL-2022-069-K). The requirement for written informed consent was waived by the ethics committee of Beijing Youan Hospital, Capital Medical University (no. LL-2022-069-K) due to the use of anonymous data collected from electronic medical record systems.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"70"}}